Literature DB >> 21192926

Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Aaron C Rising1, Jia Xu, Aaron Carlson, Vincent V Napoli, Eileen M Denovan-Wright, Ronald J Mandel.   

Abstract

The discovery of the gene mutation responsible for Huntington's disease (HD), huntingtin, in 1993 allowed for a better understanding of the pathology of and enabled the development of animal models. HD is caused by the expansion of a polyglutamine repeat region in the N-terminal of the huntingtin protein. Here we examine the behavioral, transcriptional, histopathological and anatomical characteristics of a knock-in HD mouse model with a 140 polyglutamine expansion in the huntingtin protein. This CAG 140 model contains a portion of the human exon 1 with 140 CAG repeats knocked into the mouse huntingtin gene. We have longitudinally examined the rearing behavior, accelerating rotarod, constant speed rotarod and gait for age-matched heterozygote, homozygote and non-transgenic mice and have found a significant difference in the afflicted mice. However, while there were significant differences between the non-transgenic and the knock-in mice, these behaviors were not progressive. As in HD, we show that the CAG 140 mice also have a significant decrease in striatally enriched mRNA transcripts. In addition, striatal neuronal intranuclear inclusion density increases with age. Lastly these CAG 140 mice show slight cortical thinning compared to non-transgenic mice, similarly to the cortical thinning recently reported in HD.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192926      PMCID: PMC3060971          DOI: 10.1016/j.expneurol.2010.12.017

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  96 in total

1.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

2.  Behavior in Huntington's disease: dissociating cognition-based and mood-based changes.

Authors:  Jennifer C Thompson; Julie S Snowden; David Craufurd; David Neary
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

3.  Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice.

Authors:  Vanessa C Wheeler; Claire-Anne Gutekunst; Vladimir Vrbanac; Lori-Anne Lebel; Gabriele Schilling; Steven Hersch; Robert M Friedlander; James F Gusella; Jean-Paul Vonsattel; David R Borchelt; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2002-03-15       Impact factor: 6.150

4.  Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.

Authors:  Zhao-Xue Yu; Shi-Hua Li; Huu-Phuc Nguyen; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2002-04-15       Impact factor: 6.150

5.  Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.

Authors:  Edmond Y W Chan; Ruth Luthi-Carter; Andrew Strand; Steven M Solano; Sarah A Hanson; Molly M DeJohn; Charles Kooperberg; Kathryn O Chase; Marian DiFiglia; Anne B Young; Blair R Leavitt; Jang-Ho J Cha; Neil Aronin; Michael R Hayden; James M Olson
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

6.  Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.

Authors:  Ruth Luthi-Carter; Andrew D Strand; Sarah A Hanson; Charles Kooperberg; Gabriele Schilling; Albert R La Spada; Diane E Merry; Anne B Young; Christopher A Ross; David R Borchelt; James M Olson
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

7.  Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.

Authors:  B Gómez-Ansón; M Alegret; E Muñoz; G C Monté; E Alayrach; A Sánchez; M Boada; E Tolosa
Journal:  Parkinsonism Relat Disord       Date:  2008-07-15       Impact factor: 4.891

8.  Sustained effects of nonallele-specific Huntingtin silencing.

Authors:  Valérie Drouet; Valérie Perrin; Raymonde Hassig; Noëlle Dufour; Gwennaelle Auregan; Sandro Alves; Gilles Bonvento; Emmanuel Brouillet; Ruth Luthi-Carter; Philippe Hantraye; Nicole Déglon
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

9.  Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.

Authors:  M J Dowie; H B Bradshaw; M L Howard; L F B Nicholson; R L M Faull; A J Hannan; M Glass
Journal:  Neuroscience       Date:  2009-06-10       Impact factor: 3.590

10.  Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.

Authors:  Edith L Pfister; Lori Kennington; Juerg Straubhaar; Sujata Wagh; Wanzhou Liu; Marian DiFiglia; Bernhard Landwehrmeyer; Jean-Paul Vonsattel; Phillip D Zamore; Neil Aronin
Journal:  Curr Biol       Date:  2009-04-09       Impact factor: 10.834

View more
  19 in total

1.  Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.

Authors:  Laura J McMeekin; Ye Li; Stephanie N Fox; Glenn C Rowe; David K Crossman; Jeremy J Day; Yuqing Li; Peter J Detloff; Rita M Cowell
Journal:  J Neurosci       Date:  2018-02-28       Impact factor: 6.167

2.  Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.

Authors:  Yi Hu; Vanita Chopra; Raman Chopra; Joseph J Locascio; Zhixiang Liao; Hongliu Ding; Bin Zheng; Wayne R Matson; Robert J Ferrante; H Diana Rosas; Steven M Hersch; Clemens R Scherzer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

3.  Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice.

Authors:  Zachary R Crook; David E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

4.  Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice.

Authors:  Alexander Murphy-Nakhnikian; Jenelle L Dorner; Benjamin I Fischer; Nathan D Bower-Bir; George V Rebec
Journal:  Neurosci Lett       Date:  2012-02-03       Impact factor: 3.046

5.  Long-term analyses of innervation and neuromuscular integrity in the Trembler-J mouse model of Charcot-Marie-Tooth disease.

Authors:  Jessica Renee Nicks; Sooyeon Lee; Kathryne Ann Kostamo; Andrew Benford Harris; Amanda M Sookdeo; Lucia Notterpek
Journal:  J Neuropathol Exp Neurol       Date:  2013-10       Impact factor: 3.685

6.  Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.

Authors:  Stephen C Fowler; Nancy A Muma
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

7.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

Review 8.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

9.  Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.

Authors:  Simon P Fisher; Michael D Schwartz; Sarah Wurts-Black; Alexia M Thomas; Tsui-Ming Chen; Michael A Miller; Jeremiah B Palmerston; Thomas S Kilduff; Stephen R Morairty
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

10.  Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.

Authors:  Yun-Ping Deng; Anton Reiner
Journal:  J Comp Neurol       Date:  2016-06-06       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.